From: Presence of gustatory and olfactory dysfunction in the time of the COVID-19 pandemic
Variable | COVID-19 Positive | COVID-19 Negative | p-value |
---|---|---|---|
Number of Patients | 43 | 668 | Â |
Fever (> 37.5 °C) | 22 (51.16%) | 214 32.04%) | <  0.0001 |
Gustatory Dysfunction | 27 (62.79%) | 156 (23.35%) | <  0.0001 |
Olfactory Dysfunction | 25 (58.14%) | 133 (19.91%) | < 0.0001 |
Visual Dysfunction | 5 (11.63%) | 80 (11.98%) | 0.8454 |
Auditory Dysfunction | 2 (4.65%) | 55 (8.23%) | 0.4569 |
Sensibility Dysfunction | 11 (25.58%) | 87 (13.02%) | 0.1353 |
Dyspnoea | 21 (48.84%) | 267 (39.97%) | 0.0254 |
Fatigue | 39 (90.70%) | 466 (69.76%) | 0.0001 |
Headache | 34 (79.07%) | 419 (62.72%) | 0.0073 |
Joint Pain | 26 (60.47%) | 309 (46.26%) | 0.0015 |
Rhinorrhea | 28 (52.69%) | 352 (52.69%) | 0.0197 |
Cough | 32 (74.42%) | 378 (56.59%) | 0.0004 |
Pharyngitis | 26 (60.47%) | 360 (53.89%) | 0.0981 |
Diarrhea | 14 (32.56%) | 177 (26.50%) | 0.8507 |
Ocular Pruritus | 18 41.86%) | 211 (31.59%) | 0.4021 |
Scrotal Pain | 0 | 13 (4.39%) | 0.7031 |